147P Pharmacokinetics, safety, and efficacy of trastuzumab deruxtecan (T-DXd) with OATP1B/CYP3A inhibitors in patients with HER2-expressing advanced solid tumours

Autor:	Ichiro Kinoshita, Caleb Lee, Emi Kamiyama, T. Fujiki, Issei Achiwa, Y-H. Im, Hironobu Minami, Y.-J. Bang, Yasuyuki Okuda, M. Karayama, Masato Takahashi, Noboru Yamamoto, C-C. Lin, Satoshi Takahashi, J. Watanabe
Rok vydání:	2020
Předmět:	Oncology medicine.medical_specialty Pharmacokinetics business.industry CYP3A Trastuzumab Internal medicine medicine In patient Hematology business medicine.drug
Zdroj:	Annals of Oncology. 31:S68-S69
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2020.03.247
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b64c12966c29c67808fb16a7cd5e82a5 https://doi.org/10.1016/j.annonc.2020.03.247 Zobrazit plný text záznamu